Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Color

Analyst Color

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Top Stories

MetLife-Spinoff Brighthouse Financial Impresses Analyst With Business Mix Improvements

By Priya Nigam
June 17, 12:47 PM
Analyst upgrades Brighthouse Financial, citing gradual business mix improvement and strong capital position. Stock has lost 23% YTD but trading at reasonable free cash flow yield.

BHF

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Health Care
  • Initiation
  • Long Ideas
  • Movers
  • Top Stories
  • Trading Ideas

Legend Biotech’s Cancer Drug, ‘The Most Attractive Product,’ Set For Growth: Analyst

By Priya Nigam
June 17, 12:15 PM
Legend Biotech analyst predicts growth for Carvykti. The Multiple Myeloma drug could become a $5B+ product.

JNJ

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Initiation
  • Long Ideas
  • Movers
  • Top Stories
  • Trading Ideas

Bowhead Specialty Has A ‘Long Runway For Growth Ahead,’ Says Bullish Analyst

By Priya Nigam
June 17, 10:46 AM
Bowhead Specialty has a long runway for growth ahead, being well positioned in the specialty casualty insurance segment.

BOW

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Cannabis
  • Emerging Market ETFs
  • Emerging Markets
  • ETFs
  • Exclusives
  • Interview
  • Management
  • Markets
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Tim Seymour On Running A Cannabis Fund: ‘We Focus On Companies Poised For Growth’

By Nicolas Jose Rodriguez
June 17, 9:26 AM
Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is renowned for recognizing the potential of the cannabis sector early on.

BTI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Long Ideas
  • Tech
  • Top Stories
  • Trading Ideas

Broadcom’s Cutting-Edge AI Networking Technology Leaves Nvidia, Marvell, Cisco Behind: JPMorgan

By Surbhi Jain
June 17, 8:04 AM
Broadcom dominates the datacenter and AI Ethernet switching market with 80% market share, driven by relentless innovation and cutting-edge

AMZN

Read More
2 minute read
  • Analyst Color
  • Equities
  • News
  • Top Stories
  • Trading Ideas

‘Nvidia Is Sucking The Oxygen Out Of The Room:’ Wealth Manager Says Stocks With ‘Good Fundamental Execution’ Can Still Decline Because Of AI Stalwart

By Shanthi Rexaline
June 17, 6:17 AM
Nvidia is second-best performer among S&P 500 stocks, thanks to its AI exposure, and the strength is expected to last multiple years.

AAPL

Read More
3 minute read
  • Analyst Color
  • Long Ideas
  • Markets
  • Media
  • News
  • Top Stories
  • Trading Ideas

S&P 500 Poised To Extend Bull Run? Market Strategist Sees ‘AI Fervor’ And Ebbing Inflation Pushing Valuation Toward Dot-com Peak

By Shanthi Rexaline
June 17, 2:30 AM
AI will likely be the market driver in the near- to mid-term and the keep the S&P 500 in an upward trending trajectory, an analyst says.

SPY

Read More
2 minute read
  • Analyst Color
  • Equities
  • Media
  • News
  • Short Ideas
  • Top Stories
  • Trading Ideas

Tesla Analyst Explains Why EV Marker Is ‘Going To Prove To Be The Next Enron’: ‘Many Fanboys Will Run For The Hills’

By Shanthi Rexaline
June 16, 6:13 PM
Tesla's fundamental problems may not go away anytime soon and the stock could be headed all the way down to $15, says a bearish analyst.

TSLA

Read More
2 minute read
  • Analyst Color
  • Cryptocurrency
  • Long Ideas
  • Markets
  • News
  • Top Stories
  • Trading Ideas

Is Bitcoin Pricey At Current Levels? ‘Rich Dad, Poor Day’ Author Robert Kiyosaki Says King Crypto ‘Not High As It’s Going To Go’

By Shanthi Rexaline
June 15, 10:24 AM
“Rich Dad, Poor Dad” author Robert Kiyosaki on Friday addressed concerns among Bitcoin (CRYPTO: BTC) skeptics regarding the pricey nature of the apex crypto.

BTC

Read More
2 minute read
  • Analyst Color
  • Equities
  • Markets
  • News
  • Tech
  • Top Stories

Apple, Nvidia Are The Most Overbought Stocks On Wall Street Amid AI Frenzy: Here Are Other Stocks With Potential For Pullback

By Rounak Jain
June 15, 6:00 AM
Apple has emerged as one of the most overbought stocks on Wall Street following its recent surge to record highs, driven by its foray into consumer-centric AI.

AAPL

Posts pagination

Previous 1 … 3 4 5 … 689 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service